摘要
Introduction: Therapy options for prostate cancer (PCa) typically are centered on docetaxel-based chemotherapy but are limited by the effects of multi-drug resistance. Recent advances have illustrated a role of contactin-1 (CNTN-1) in tumor chemoresistance, while the function and mechanism of CNTN-1 in the resistance of docetaxel in prostate cancer have not yet been elucidated. @@@ Material and methods: Docetaxel (Dox)-resistant PCa cell lines of PC3 (PC3-DR) and DU145 (DU145-DR) were established, and short hairpin RNA (shR-NA) constructs targeting CNTN-1 were generated to analyze the effect of knockdown of CNTN-1 on PCa progression. Cell Counting Kit-8 (CCK-8), flow cytometry, wound-healing, transwell and western blotting analysis were used to analyze cell proliferation, apoptosis, migration, invasion and related protein expression levels, respectively. @@@ Results: Knockdown of CNTN-1 in PC3-DR and DU145-DR cells attenuated cell proliferation, migration, invasion, EMT phenotype, and drug resistance, and increased cell apoptosis further reduced the tumorigenic phenotype. Knockdown of CNTN-1 resulted in an anti-tumor effect in the xenograft tumor model, and decreased activity of the phosphoinositide 3-kinase (PI3K/Akt signaling pathway both in vitro and in vivo. @@@ Conclusions: The results of the present study suggest that downregulation of CNTN-1 may be an important mechanism to reverse chemoresistance in Dox-resistant PCa progression, thus shedding light on the development of novel anti-tumor therapeutics for the treatment of PCa.
学科与关键词
- The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatmentCheng, Bisheng; Li, Lingfeng; Wu, Yongxin; Luo, Tianlong; Tang, Chen; Wang, Qiong; Zhou, Qianghua; Wu, Jilin; Lai, Yiming; Zhu, Dingjun*; Du, Tao; Huang, Hai*Cell and Bioscience, 2023, 13(1): 211.被引 1
- Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage responseYan Judy; Tang Damu*Experimental Cell Research, 2014, 328(1): 132-142.
- LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin PathwayChen, Binshen; Xu, Kai; Zhang, Yiming; Xu, Peng; Li, Chaoming; Liu, Jun; Xu, Yawen*Cancers, 2023, 15(6): 1902.
